These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23043667)

  • 1. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival.
    Witjes CD; Karim-Kos HE; Visser O; de Vries E; IJzermans JN; de Man RA; Coebergh JW; Verhoef C
    HPB (Oxford); 2012 Nov; 14(11):777-81. PubMed ID: 23043667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
    Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
    Shaib YH; Davila JA; McGlynn K; El-Serag HB
    J Hepatol; 2004 Mar; 40(3):472-7. PubMed ID: 15123362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers.
    Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis.
    Spolverato G; Bagante F; Tsilimigras D; Ejaz A; Cloyd J; Pawlik TM
    J Surg Oncol; 2019 Mar; 119(3):278-287. PubMed ID: 30554420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
    Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
    Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
    Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma.
    Jiang BG; Ge RL; Sun LL; Zong M; Wei GT; Zhang YJ
    Can J Gastroenterol; 2011 Nov; 25(11):603-8. PubMed ID: 22059167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma.
    Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC
    Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional disparities affect treatment and survival of patients with intrahepatic cholangiocarcinoma--a Texas Cancer Registry analysis.
    Kneuertz PJ; Kao LS; Ko TC; Wray CJ
    J Surg Oncol; 2014 Sep; 110(4):416-21. PubMed ID: 24889699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.
    Chang WW; Hsiao PK; Qin L; Chang CL; Chow JM; Wu SY
    Radiother Oncol; 2018 Nov; 129(2):284-292. PubMed ID: 30279046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass.
    Uno M; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surg Today; 2012 Dec; 42(12):1189-94. PubMed ID: 22350300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
    Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
    HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.